Topic summary

Oral versus injected administration claims for BPC-157

Compounds › Repair & healing peptides BPC-157 observational data preprint TB-500 needs a source

This is a generated summary. It shows the 5 most-liked posts from a topic of 25, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.

m.radichTL29 Mar 2026#4

ra.mensa, post #1: Oral versus injected administration claims for BPC-157 — setting out what I have, and where I think it stops being reliable. I have spent a fortnight trying to pin oral versus injected administration claims down and I want to set out where I have got to, because I suspect the honest answer is duller than the thread this will produce.… Go to post

I keep a log for oral versus injected administration claims specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled it.

24 likes in reply to #1 5mo

j.ivaturiTL211 Mar 2026#8

a.adeyemi, post #2: Adding a data point of agreement rather than a data point. Go to post

The confident answers on oral versus injected administration claims and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.

17 likes in reply to #2 5mo

b.brandtTL213 Mar 2026#13

Offering a way to settle oral versus injected administration claims rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the noise, the question was not answerable at this precision.

20 likes 5mo

IbrahimoviTL2Member15 Mar 2026#18

Coming back to post #14, because the follow-up matters more than the original answer.

Route arguments — local versus systemic — are made confidently in this subcategory on very little published basis. The honest position is that the comparison has not been studied in humans.

If that is already documented somewhere, ignore me and link it.

29 likes 4mo

k.salinasTL215 Mar 2026#20

Worth separating two things that post #18 runs together.

Worth stating the null on oral versus injected administration claims before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.

19 likes 4mo

Read the full topic (25 posts)

Suggested topics

Topic	Participants	Replies	Views	Activity
Publication patterns in the BPC-157 literature, examined Compounds › Repair & healing peptides preprint BPC-157 TB-500 needs a source Solved Posting this under the heading it deserves: Publication patterns in the BPC-157 literature, examined Everything below is what sits behind that. Putting the numbers in the first post, because a question about…	+40	45	3.4k	21h
BPC-157: what the rodent literature actually shows, and what it does not Compounds › Repair & healing peptides observational data preprint BPC-157 needs a source BPC-157: what the rodent literature actually shows, and what it does not — setting out what I have, and where I think it stops being reliable. I would like to know what people here actually do about BPC-157,…	+44	48	3k	10mo
Why plausible mechanism is not evidence of effect — one year on Compounds › Repair & healing peptides needs a source preprint BPC-157 Solved Closed The question in the title: Why plausible mechanism is not evidence of effect — one year on I will give what I have already checked below so nobody repeats it. What changes if the standard account of plausible…	+3	7	3.6k	13mo
Reading a preclinical wound-healing model and its relevance to a human tendon Compounds › Repair & healing peptides TB-500 preprint observational data Wiki Closed On the subject in the title: Reading a preclinical wound-healing model and its relevance to a human tendon Working notes rather than a conclusion. Posting a small dataset on reading a preclinical…	+149	160	3.3k	20mo
Stability of BPC-157 in solution: what has been measured — one year on Compounds › Repair & healing peptides needs a source observational data preprint BPC-157 On the subject in the title: Stability of BPC-157 in solution: what has been measured — one year on Working notes rather than a conclusion. A narrow question about Stability of BPC-157, deliberately narrow,…	+84	98	7.8k	18h

Related topics — sharing the tags BPC-157, observational data, preprint

Topic	Participants	Replies	Views	Activity
A structured critique template this community uses Evidence › Study critique observational data effect size risk of bias A structured critique template this community uses — setting out what I have, and where I think it stops being reliable. Structured critique template — I have the observation and I do not trust my…		2	18k	1d
When "no data" is the complete and final answer Compounds › Other compounds custom synthesis mislabelling needs a source research use only Solved Asking directly, because I could not find a straight answer: When "no data" is the complete and final answer Asking about the compound itself rather than about a trial of it. I have read the maintained page…	+154	165	6.3k	15mo
Melanocortin agonists: mechanism and the documented adverse profile Compounds › Other compounds needs a source mislabelling research use only custom synthesis Melanocortin agonists: mechanism and the documented adverse profile — setting out what I have, and where I think it stops being reliable. Melanocortin agonists, and specifically the version of it that the…	+7	11	5.5k	20mo
What TRIUMPH is designed to answer, and why we should not pre-empt it Compounds › Retatrutide retatrutide effect size TRIUMPH programme preprint Solved What TRIUMPH is designed to answer, and why we should not pre-empt it I have a specific reason for asking rather than idle curiosity, and the context is below. TRIUMPH keeps being re-asked here and I think…	+4	8	142	6h
The retatrutide phase 2 obesity paper, read closely Compounds › Retatrutide preprint effect size TRIUMPH programme Posting this under the heading it deserves: The retatrutide phase 2 obesity paper, read closely Everything below is what sits behind that. Retatrutide phase 2 obesity paper, from the point of view of someone…		2	65k	10mo